Incyte (INCY) Other Accumulated Expenses (2017 - 2022)
Incyte (INCY) posted Other Accumulated Expenses of $209.5 million for Q2 2022, up 181.99% on a QoQ basis from $74.3 million in Q1 2022, and up 64.68% year-over-year from $127.2 million in Q2 2021.
Incyte (INCY) Other Accumulated Expenses (2017 - 2022) Analysis & Trends
Incyte's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $209.5 million for Q2 2022.
- Quarterly Other Accumulated Expenses rose 64.68% year-over-year to $209.5 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $209.5 million (up 64.68% YoY) and the FY2021 annual result came in at $168.4 million, up 379.64% from the prior year.
- Other Accumulated Expenses was $209.5 million for Q2 2022 at Incyte, up from $74.3 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $209.5 million in Q2 2022 and bottomed at $20.1 million in Q1 2019.
- A 5-year average of $80.6 million and a median of $72.5 million in 2020 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2021 — Other Accumulated Expenses soared 379.64% — and 2022, when it plunged 32.52%.
- Incyte's Other Accumulated Expenses stood at $25.1 million in 2018, then surged by 67.61% to $42.0 million in 2019, then dropped by 16.5% to $35.1 million in 2020, then surged by 379.64% to $168.4 million in 2021, then rose by 24.4% to $209.5 million in 2022.
- Business Quant data shows INCY's Other Accumulated Expenses at $209.5 million in Q2 2022, $74.3 million in Q1 2022, and $168.4 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Incyte | 23.47 Bn | 19.46 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 209.50 Mn |
| Mar 31, 2022 | 74.29 Mn |
| Dec 31, 2021 | 168.41 Mn |
| Sep 30, 2021 | 74.65 Mn |
| Jun 30, 2021 | 127.22 Mn |
| Mar 31, 2021 | 110.10 Mn |
| Dec 31, 2020 | 35.11 Mn |
| Sep 30, 2020 | 49.56 Mn |
| Jun 30, 2020 | 71.96 Mn |
| Mar 31, 2020 | 73.05 Mn |
| Dec 31, 2019 | 42.05 Mn |
| Jun 30, 2019 | 47.40 Mn |
| Mar 31, 2019 | 20.08 Mn |
| Dec 31, 2018 | 25.09 Mn |
| Dec 31, 2017 | 22.81 Mn |